0000000000179503

AUTHOR

Awad Al-omari

showing 1 related works from this author

Outcome of COVID19 in Patients With Osteogenesis Imperfecta: A Retrospective Multicenter Study in Saudi Arabia

2022

BackgroundAlthough genetic diseases are rare, children with such conditions who get infected with COVID-19 tend to have a severe illness requiring hospitalization. Osteogenesis imperfecta (OI) is a rare genetic disorder of collagen resulting in fractures and skeletal deformities. Kyphoscoliosis, restrictive lung disease, and pneumonia worsen the prognosis of patients with OI. The use of bisphosphonate improves bone mineral density (BMD) and reduces fractures in OI. There is no literature describing the impact of COVID-19 in patients with OI.MethodologyA retrospective multi-center study was performed in three hospitals in Jeddah and Riyadh, Saudi Arabia, from March 1st, 2020, until August 31…

AdultMaleCOVID - 19bisphosphonateAdolescentEndocrinology Diabetes and MetabolismSaudi Arabiaosteogenesis imperfectaDiseases of the endocrine glands. Clinical endocrinologyFractures BoneYoung AdultEndocrinologyBone DensityHypothesis and TheoryHumansChildRetrospective StudiesDiphosphonatesSARS-CoV-2COVID-19PrognosisRC648-665HospitalizationfractureoutcomeFemaleFollow-Up StudiesFrontiers in Endocrinology
researchProduct